Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing ...

Miscellaneous PIERER Mobility AG: Restructuring plans for KTM AG, KTM Components GmbH, and KTM Forschungs & Entwicklungs GmbH are legally binding 17.06.2025 / 07:33 CET/CEST The issuer is solely ...

Aduna , the global aggregator of network APIs, and NTT DOCOMO, Inc., one of Japan's leading mobile operators with over 91 million subscribers, today announced an intention to ...

MedHub-AI , pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR ® , its groundbreaking ...

Aduna , the global aggregator of network APIs, today announced that it has entered into a strategic commercial partnership with SoftBank Corp. ("SoftBank") as part of a ...

Stan Miller appointed CEO to lead United Group as it strategically refocuses its business on EU markets following successful sale of non-EU operations Together with Stan, Libor Voncina appointed ...

Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor ...

Quarter Results Q1 2025: Wolftank Group increases sales by 10% to EUR 25.7 million 12.06.2025 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement.

This new feature will turn the operational database into a powerful native AI engine, responding to the growing demand for engineering teams to deliver ...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): Expansion SBO inaugurates expanded facility in Vietnam and strengthens global supply chain flexibility 12.06.2025 / 10:00 CET/CEST ...

Annual Results voestalpine AG: voestalpine generates solid result in the 2024/25 business year despite difficult environment 04.06.2025 / 07:30 CET/CEST The issuer is solely responsible for the ...

Vienna-based researchers are now trying to combine molecular biological markers with other diagnostic procedures, which could provide clues to possible therapies.